Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2020

May 15, 2020

34491_dirs_2020-05-15_ffa65457-9e56-47b2-a2d6-a43ffccc2a2c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2020-05-13

Reporting Person: Schinazi Raymond F (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-05-13 Stock Option (Right to Buy) $6.62 A 41038 Acquired 2030-05-12 Common Stock (41038) Direct

Footnotes

F1: The option vests on the earlier of May 13, 2021 or the day immediately prior to the date of the next annual meeting of the Company's stockholders occurring after May 13, 2020.